Noscapine HCl DA

Quick links

Choose a section

Quick links to important sections

Advertisements

Noscapine HCl DA

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Noscapine HCl DA

Quick Facts

Property Description
Active ingredient Noscapine
Form Tablets, Syrup
Pharmacological class Antitussive agent (Centrally acting)
Common use Suppression of cough
Origin Natural alkaloid (Opium poppy derivative)

What Type of Medicine is Noscapine Hydrochloride?

Noscapine Hydrochloride is the specific salt form of the active ingredient Noscapine, a dedicated centrally acting antitussive agent whose primary function is to suppress the cough reflex. As a pharmaceutical preparation, it is commonly supplied for oral administration in various forms, including tablets and syrup.

The active component is chemically classified as a phthalideisoquinoline alkaloid, a type of natural alkaloid found in the opium poppy (Papaver somniferum). Crucially, despite this plant origin, Noscapine is distinct; it is widely recognized as a non-narcotic antitussive, listed under the Anatomical Therapeutic Chemical (ATC) code R05DA07. This distinction means that Noscapine helps manage coughs without producing euphoric or addictive effects. The use of the hydrochloride salt ensures greater stability and reliable absorption of the active ingredient.


How Does Noscapine Differ from Narcotic Cough Medicines?

Noscapine is differentiated from traditional opioid-derived cough suppressants by its non-narcotic action; it effectively modulates the cough center in the brainstem without carrying the risks of addiction or dependence. This characteristic is clinically recognized as a differentiating factor when selecting a medication for short-term cough relief in situations where sedation or habit-forming potential must be minimized.

The core functional difference is the lack of sedative effects and minimal potential for respiratory depression associated with Noscapine, which contrasts with the profile of narcotic antitussives. This highly targeted and non-sedating action allows Noscapine to provide effective symptomatic relief for irritating dry coughs. Patients can expect reliable relief from coughing with a low risk of drowsiness or dependence.

Advertisements

What side effects are possible with Noscapine HCl DA?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety restrictions for Noscapine Hydrochloride, as reported in government regulatory documents and pharmacovigilance reports.

Documented Adverse Reactions

Adverse reactions associated with Noscapine are grouped by the body system they affect. While standardized frequency classifications are not uniformly available across all regulatory summaries, reactions have been reported across several System-Organ Classes:

System-Organ Class Common Adverse Reactions Listed
Nervous System Drowsiness, Lightheadedness, Headache, Dizziness
Gastrointestinal Nausea, Vomiting, Constipation, Abdominal pain
Immune/Skin Urticaria (hives), Pruritus (itching), Swelling

Serious Safety Concerns

Rare but clinically significant adverse reactions linked to severe hypersensitivity have been documented in pharmacovigilance reports. These include:

  • Angioedema: Severe localized swelling, including swelling of the face, tongue, and throat.
  • Laryngeal Edema and Respiratory Failure: These are reported serious complications, often linked to acute allergic responses.

Regulatory Safety Restrictions and Cautions

Safety statements in official labeling define specific groups and situations where use is restricted or requires caution:

  • Contraindication: The medicine is strictly contraindicated in individuals with a known hypersensitivity or allergy to Noscapine or any of its components.
  • Population Cautions: Caution is advised for elderly patients, who may have an increased risk of adverse events. Additionally, specific caution is noted for patients with hepatic or renal impairment due to the potential for drug accumulation.
  • Drug Interactions (Safety Consequence): Concomitant use with CNS depressants (e.g., alcohol) may enhance sedative effects. Use with warfarin may increase the risk of its anticoagulant effect.

This information is derived exclusively from regulatory safety data and defines the medicine's official risk profile.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations of Noscapine overdose and the corresponding emergency actions mandated by regulatory authorities. The information is derived exclusively from governmental and official drug labeling sources.


Documented Overdose Manifestations

Overdose with Noscapine, especially at high doses, may lead to documented adverse manifestations primarily involving the central nervous system (CNS) and gastrointestinal system. Regulator-listed symptoms include nausea, vomiting, headache, dizziness, and confusion. More severe CNS manifestations documented in official sources include agitation, seizures, and coma, alongside a risk of respiratory failure.


Officially Required Emergency Actions

In all suspected or confirmed cases of overdose, immediate emergency medical treatment or contacting a doctor/physician is mandated. Official instructions require calling a POISON CENTER or physician if the product is swallowed and the patient feels unwell, as urgent hospital treatment is likely needed for management. Elderly patients, specifically, may be at risk for respiratory failure.


Supportive Measures and Antidote

Management of Noscapine overdose focuses on a program of symptomatic and supportive therapy. Regulatory documentation indicates that no specific antidote for Noscapine overdose is formally known or documented in the primary labeling.

Advertisements

Therapeutic Uses of Noscapine HCl DA

What Noscapine HCl DA Treats: Main Uses and Benefits

Noscapine is used in situations involving certain distressing symptoms, applied to help with the temporary management of coughs. This medication is relevant for easing symptoms related to inflammatory or irritative states.

The medicine is commonly used across conditions presenting with acute episodes and may be applied in contexts where additional symptomatic support is needed. It is applied in addressing symptom clusters that may become intense or disruptive, such as the dry, hacking, and irritating pattern of coughs.

It is relevant in clinical settings that involve acute symptom patterns, offering support that helps ease the overall symptom burden. The medication may assist with managing symptoms that interfere with daily functioning, such as cough-induced sleep disruption, supporting patients during difficult episodes by easing distress.


Quick Fact: Symptom Management Focus It is relevant for managing non-productive coughs (dry and persistent), applied in scenarios where additional management of discomfort is required.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility: Who Can and Cannot Use Noscapine HCl DA

Noscapine HCl DA is subject to specific population eligibility rules defined by national regulatory authorities. These rules establish absolute contraindications for certain groups and place strict limitations on use for others, primarily based on age, physiological status, and underlying respiratory health.


Absolute Contraindications (Must Not Use)

Population/Condition Regulatory Status
Children under 30 months of age Contraindicated
Known hypersensitivity to the active substance or excipients Contraindicated
Respiratory Failure or severe conditions like Asthma/COPD-related cough Contraindicated
Concurrent use with Monoamine Oxidase Inhibitors (MAOIs) Contraindicated

Populations with Use Restrictions

Use is not recommended during pregnancy and breastfeeding. Additionally, the medicine is generally not normally recommended for children under 6 years of age, often due to issues related to available dosage forms. Older adults are considered a special patient group and may require specific medical evaluation due to a noted risk profile.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Noscapine has the potential to interact with several classes of medicinal products, largely due to its effect on the body's drug-metabolizing enzymes. The most critical combinations are contraindicated or require strict caution, as documented in regulatory information.

Simultaneous use with opioid agonists and antagonists (e.g., morphine derivatives) is contraindicated because of the risk of reduced antitussive effectiveness and the potential for a withdrawal syndrome. Noscapine should also not be combined with expectorants or mucolytics.

Caution is necessary when Noscapine is co-administered with other Central Nervous System (CNS) depressants, including alcohol and hypnotics, as this may enhance sedative effects, potentially impairing concentration and coordination.

Noscapine may increase the effect of certain anticoagulants, such as warfarin, by inhibiting the metabolism of the anticoagulant, leading to a higher risk of bleeding. The drug can also decrease the metabolism and increase the serum concentration of numerous other medicines (e.g., certain statins and anti-cancer drugs), primarily through its ability to inhibit the Cytochrome P450 enzyme systems (specifically CYP2C9 and CYP2C19).

Advertisements

Mechanism of Action

Central Mechanism via Sigma-1 Receptor Activation

The core mechanism of Noscapine HCl involves acting as an agonist (an activator) at the Sigma-1 (sigma1) Receptor, a specialized protein found on neurons within the brainstem. This interaction engages the CNS pathways that modulate the cough reflex arc . This central mechanism is distinct from those that influence peripheral airway activity or local smooth muscle tone.


Modulation of the Medullary Cough Threshold

Activation of the sigma1 receptor alters neuronal signaling within the medullary cough center, resulting in a localized reduction in neuronal excitability. This physiological change leads to an elevation of the cough threshold. Consequently, a higher stimulus intensity is necessary to generate the efferent cough motor command. This mechanism does not heavily engage mu-opioid pathways, resulting in an absence of the pronounced generalized CNS depression often associated with those receptors.


Function as a Symptomatic Neurological Modulator

The mechanism acts purely as a neurological modulator by limiting the output of the cough reflex, while the biological factors that initiate the afferent stimuli (e.g., inflammation) remain unaddressed by this specific pathway. The mechanism modifies the signaling dynamics exclusively within the reflex arc. This confines the effect to pathway modulation, with the primary etiology of the afferent stimulus remaining outside the mechanism's scope.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Noscapine HCl DA — Official Administration Guidelines

This section outlines the non-advisory, labeled instructions for Noscapine Hydrochloride administration.

Administration scope Detail
Route of administration Exclusively Oral (by mouth).
Dosing schedule (Adults) Single oral doses may range up to 50 mg of the tablet formulation. Dosing is regulated by a strict maximum recommended daily intake that must not be exceeded in 24 hours.
Timing in relation to meals Administration is conditioned on the time relationship with meals. The medicine is directed to be taken on an empty stomach, often specified as approximately 30 minutes before or 2 hours after eating.
Preparation requirements Liquid formulations (syrup/solution) must be measured accurately using a dedicated dose-measuring cup or spoon, and not a standard household utensil.
Age-group administration rules Children 6–14 Years: A lower, weight- or age-adjusted dose is typically prescribed, such as 25 mg of the tablet formulation, with a defined 24-hour maximum. Children 2–6 Years: Use is subject to specific restrictions and lower dose limits, reflecting caution for antitussives in young children.
Missed-dose rules For a missed dose, the procedure is to take the dose as soon as the omission is noticed, unless the next dose is almost due. The official instruction is to skip the missed dose and resume the regular schedule, without taking a double dose to compensate.

Connection to the overall use protocol:

Official instructions establish that Noscapine HCl must be taken orally under specific intake conditions (on an empty stomach) and according to precise, age-group-dependent dose ranges and schedules. This framework mandates adherence to a specified dosing frequency and maximum limits, formalizing the drug's use as a short-course antitussive treatment.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Noscapine HCl DA


Evidence for Use in Symptomatic Acute Cough

The primary research for Noscapine HCl involves Randomized Controlled Trials (RCTs) and observational studies which explore how symptoms are monitored and change over time. This research has examined the temporary symptomatic management of dry, irritating coughs, which are outcomes linked to inflammatory or irritative states. Studies explored patient-reported outcomes describing perceived discomfort, such as the frequency and intensity of coughing fits.

Studies conducted during periods of increased symptom activity tracked and recorded symptom measurements in the observed populations, particularly over short observation intervals. These findings describe patterns observed in the studies related to variations in cough measurements. However, findings were mixed across different studies, which is often related to variations in study design, such as whether a single ingredient or a combination product was used.


Comparing Noscapine HCl in Studies

Research examined Noscapine HCl in trials by looking at the use of two main types of control groups: placebo (an inactive treatment) and other established cough medicines. These comparative studies were evaluated in contexts involving fluctuating or unstable symptoms, with the aim of monitoring physiological strain or stress.

Data describe the patterns evaluated for Noscapine HCl when outcomes were compared against these control groups. For instance, the studies observed differences in outcome measurements when comparing Noscapine HCl to placebo or active comparators. However, the available comparative evidence is often lacking when looking at large-scale, recent meta-analyses, and evidence quality varies across studies.


Duration of Study and Long-Term Follow-up

Research exploring short-term symptom changes for Noscapine HCl typically focuses on defined time intervals that align with the acute nature of a cough, meaning follow-up durations were limited. In most trials, studies monitored patients for only a few days, reflecting the temporary application of the medicine. As a result, long-term effects are not yet fully established because limited data are available for long-term outcomes.


Understanding Research Uncertainty and Limitations

One key research limitation is that sample sizes were modest in some of the pivotal studies, which affects the generalizability of the findings. Furthermore, evidence quality varies across studies. Another area of uncertainty is the heterogeneity (variability) found across different studies regarding the specific formulations and control groups used. The scope of the results is limited to the populations studied and the specific conditions under which they were conducted.

Key Studies & References ATC Classification System: R05DA07 Noscapine

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Noscapine HCl DA (FAQ)

Q: What specific symptom or condition does Noscapine HCl DA treat?

Regulatory documents indicate that Noscapine HCl DA is approved for the temporary symptomatic management of dry, irritating coughs. Official information describes its role in managing the symptom of dry, irritating coughs, especially when not associated with phlegm.

Q: What is the general drug category that Noscapine HCl DA belongs to?

Official drug classifications define Noscapine HCl as a centrally acting antitussive agent, meaning it works in the central nervous system (CNS) to suppress cough. This classification describes medicines that modulate the cough reflex.

Q: Can Noscapine HCl DA cause drowsiness or affect alertness?

According to regulatory safety information, drowsiness and dizziness are noted side effects of this medicine. Due to this potential effect, official warnings advise exercising caution related to tasks that require concentration, such as driving or operating machinery.

Q: Are there official restrictions regarding who can take Noscapine HCl DA?

Official documents contain specific restrictions regarding who can use this medicine, including age-related rules for children. Official documents note specific populations that require caution or contraindication, including patients with certain pre-existing respiratory issues (such as cough related to smoking, COPD, or asthma).

Q: Does Noscapine HCl DA have known interactions with common over-the-counter medicines?

Official drug interaction information describes a prohibition against simultaneous use of Noscapine HCl DA with expectorants or mucolytics. These ingredients are often found in over-the-counter cough and cold medicines.

Q: Is it necessary to avoid alcohol while using Noscapine HCl DA?

Official warnings advise caution when this medicine is used with alcohol. The combination may increase the risk of enhanced sedative effects, potentially impacting coordination and alertness.

Q: What kind of studies have been published regarding Noscapine HCl DA safety?

Regulatory reviews of the research evidence confirm that safety and tolerability were monitored and reported across various clinical trials. These studies, including controlled and observational trials, reported on adverse events and how well the medicine was tolerated.

Q: Why do people confuse Noscapine HCl DA with opioid medications?

Confusion often arises because the medicine is derived from the opium poppy alkaloid family. However, official mechanism descriptions clarify that it works primarily on the Sigma-1 receptor, which is a pathway distinct from the mu-opioid receptors associated with typical analgesic or addictive effects.

Q: How does the body eliminate (metabolize) Noscapine HCl DA?

Regulatory information on how the drug is processed indicates that it affects the body's Cytochrome P450 enzyme systems (specifically CYP2C9 and CYP2C19). These enzymes are crucial proteins in the liver responsible for metabolizing many drugs and substances.

Q: What dosage forms (e.g., tablet, capsule, liquid) is Noscapine HCl DA available in?

The medicine is available in several forms for oral use, including both tablet formulations and liquid preparations, such as syrups or solutions. The specific form available may vary by country or brand.

Q: What are the differences between Noscapine HCl DA oral tablet and syrup formulations?

Regulatory administration instructions note that liquid forms must be measured accurately using a dedicated measuring device, such as a dosing cup or spoon. In contrast, tablet formulations are simply swallowed whole, without any specific measuring required.

Q: Is the mechanism of action for Noscapine HCl DA fully understood?

Official documents provide detailed information describing the known mechanism of action. This includes its function as an agonist (activator) at the Sigma-1 receptor to raise the medullary cough threshold, which reduces the body's sensitivity to cough triggers.

Q: Is Noscapine HCl DA considered a controlled substance?

According to official information, Noscapine HCl does not typically exhibit the analgesic (pain-relieving) or addictive qualities associated with controlled opioid substances. Its antitussive effect is achieved through a different central pathway.

Q: Is it possible to use Noscapine HCl DA on a long-term basis?

Official warnings advise caution with the duration of use. Regulatory documents describe dependence as a potential risk associated with long-term use, especially when doses exceed those prescribed.

Q: What is the most common side effect reported by users of Noscapine HCl DA?

The most commonly reported side effects listed in regulatory documents are generally mild. These frequently include nausea, vomiting, headache, dizziness, and drowsiness.

Q: Are there any serious or less common side effects associated with Noscapine HCl DA?

Regulatory information notes less common but more serious effects that require attention. These include signs of an allergic reaction, such as swelling of the face or difficulty breathing, and rare disturbances in liver function.

Q: What is the safety profile of Noscapine HCl DA for use during pregnancy?

Regulatory information advises that this medicine is generally not recommended for use by pregnant women unless deemed necessary by a clinician. Official information states that the potential risks and benefits in this situation should be assessed by a healthcare professional.

Q: Is Noscapine HCl DA generally safe for individuals over 65 (seniors)?

Official warnings advise that elderly patients may be at a higher risk of experiencing certain adverse effects, such as respiratory failure, necessitating a careful review of use. Regulatory information suggests these populations may require special caution.

Q: Are there any specific foods or dietary supplements that interact with Noscapine HCl DA?

While specific food interactions may not be universally listed, official warnings emphasize the reporting of all current medications, herbs, and supplements to a health professional, due to the drug's potential for various metabolic interactions in the body.

Q: What medical conditions are listed as contraindications for Noscapine HCl DA use?

Official documents describe contraindications for use in patients who have a known allergy or hypersensitivity to the medicine. Caution is also specifically advised for individuals whose cough is related to pre-existing conditions like smoking, COPD (Chronic Obstructive Pulmonary Disease), or asthma.

Q: Can a person with high blood pressure safely use Noscapine HCl DA?

Official warnings advise caution for patients with existing high blood pressure (hypertension). This is due to noted cardiovascular side effects, such as changes in heart rate, and an increased risk of intracranial hemorrhage reported in some warnings.

Q: What warnings exist for individuals taking Noscapine HCl DA who have liver or kidney issues?

Regulatory reports have noted rare cases of liver function disturbances, such as the appearance of jaundice, dark urine, and unusual fatigue. Regulatory reports note that if any of these signs are observed, immediate medical evaluation is advised.

Q: What are the official recommendations for storing Noscapine HCl DA?

Official product labeling specifies the exact storage requirements to maintain the medicine's stability. These conditions typically include a specific temperature range and instructions for protecting the drug from light or moisture.

Q: What is the proper way to dispose of unused or expired Noscapine HCl DA?

While detailed instructions vary locally, official safety data sheets usually advise that unused or expired medicine must be disposed of through an authorized local waste management company. This ensures that the drug is handled and disposed of safely.

Q: Is there a risk of physical dependence with Noscapine HCl DA?

Regulatory documents describe physical dependence as a potential risk. While the medicine is not typically associated with opioid addiction, regulatory documents state that long-term use or taking higher-than-prescribed doses may lead to physical dependence.

Q: What are the known signs of taking too much Noscapine HCl DA?

Regulatory reports on acute toxicity outline symptoms that may occur if too much of the medicine is taken. These symptoms can include severe nausea, confusion, agitation, respiratory failure, and in the most serious cases, seizures or coma.

Q: What patient counseling points are typically emphasized by pharmacists for Noscapine HCl DA?

Key counseling points usually align with major regulatory warnings to help ensure safe use. These include adhering strictly to prescribed dose limits, avoiding or limiting the use of alcohol, and being aware of the signs of an allergic reaction or potential overdose.

Q: Is Noscapine HCl DA available as a generic drug or only under a brand name?

Regulatory and chemical registries list Noscapine HCl as the international non-proprietary name (INN), which is the recognized generic substance. This generic substance may then be marketed and available under various brand names.

Q: Why does Noscapine HCl DA sometimes cause mild dizziness?

Dizziness is included in the official regulatory documents as a recognized and commonly reported side effect of the medicine. This is a known outcome associated with the drug's properties.

Q: What should be done if I suspect an interaction between Noscapine HCl DA and another drug?

Official guidance advises that immediate advice from a healthcare professional should be sought if a drug interaction is suspected. This includes situations where unexpected symptoms or side effects occur after combining Noscapine HCl DA with another medicine.

Advertisements

How should Noscapine HCl DA be stored and disposed of?

How to Store and Dispose of Noscapine HCl DA

The official storage conditions for Noscapine Hydrochloride (HCl) are based on regulatory mandates designed to ensure the product’s chemical stability and public safety.


Storage Requirements

Condition Regulatory Mandate
Temperature Store at room temperature; typically below 25 C or 30 C as defined by the product label.
Protection Must be protected from light and stored in a tightly sealed or well-closed container to prevent moisture ingress.
Safety The medicine must be kept out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Disposal of any unused or expired Noscapine HCl must be conducted in accordance with local regulations for pharmaceutical waste. Products should not be discarded by flushing them down a toilet or pouring them into a drain, as this prevents environmental contamination and misuse. Check with local authorities for drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Noscapine HCl DA found in:

A-Z Index: